BrainStorm Cell Therapeutics Inc. To Present at ILSI-Biomed Israel 2010

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics today announced that Rami Efrati, BrainStorm’s CEO, will be presenting at the 9th National Life Science and Technology Week ILSI-Biomed Conference, Israel 2010. The presentation will be given on Monday June 14, 2010 during the BioPharma Session being held from 4:30 p.m. to 6:30 p.m. Israel time.

MORE ON THIS TOPIC